<h1>India Seeks Easier Market Access for Generic Drugs in China at Shanghai Pharma Workshop.</h1> A workshop on regulatory systems in the pharmaceutical sector was held in Shanghai, China, on June 21, 2019, organized by the National Medical Products Administration (NMPA) and the Central Drugs Standard Control Organisation (CDSCO). The event aimed to benefit Indian pharmaceutical companies by discussing regulatory processes, drug registration, and compliance in China. India urged China to ease market access for its generic drugs by addressing regulatory hurdles like approval delays and unclear guidelines. Efforts to boost Indian pharma exports include awareness programs, B2B meetings, and a Memorandum of Understanding between Indian and Chinese pharmaceutical councils.